Gamida Cell Ltd. (GMDA)
(Delayed Data from NSDQ)
$9.51 USD
-0.67 (-6.58%)
Updated Feb 25, 2021 04:00 PM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank | Definition | Annualized Return |
---|---|---|
1 | Strong Buy | 24.41% |
2 | Buy | 17.88% |
3 | Hold | 9.48% |
4 | Sell | 5.03% |
5 | Strong Sell | 1.87% |
S&P | 500 | 10.70% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
3-Hold of 5 3
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
Value Score | A |
---|---|
Growth Score | A |
Momentum Score | A |
VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
C Value D Growth C Momentum D VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Zacks News
Gamida Cell (GMDA) Jumps: Stock Rises 8.4%
by Zacks Equity Research
Gamida Cell (GMDA) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
EBSNegative Net Change GMDANegative Net Change
medical
Company News for Oct 7, 2020
by Zacks Equity Research
Companies in the news are: KNSA, GMDA, BNTX, NAKD
NAKDNegative Net Change KNSANegative Net Change GMDANegative Net Change BNTXNegative Net Change
finance medical
Gamida Cell (GMDA) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Gamida Cell (GMDA) will provide updates on its pipeline candidates when it releases second-quarter 2020 results.
ALKSNegative Net Change AGENNegative Net Change ACADNegative Net Change GMDANegative Net Change
biotechs
Has Gamida Cell (GMDA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (GMDA) Outperforming Other Medical Stocks This Year?
GMDANegative Net Change
momentum-stocks sectors stock-market-sectors
Axcella Health (AXLA) Jumps: Stock Rises 5.9%
by Zacks Equity Research
Axcella Health (AXLA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
GMDANegative Net Change AXLAPositive Net Change
medical
Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%
by Zacks Equity Research
Ovid Therapeutics (OVID) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
OVIDNegative Net Change GMDANegative Net Change
medical
Gamida Cell (GMDA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Gamida Cell (GMDA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GMDANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Top Ranked Momentum Stocks to Buy for May 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 28th.
NCNANegative Net Change GMDANegative Net Change AXUNegative Net Change AAWWNegative Net Change
airlines medical
Gamida Cell (GMDA): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Gamida Cell (GMDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
GMDANegative Net Change
medical
Top Ranked Momentum Stocks to Buy for May 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 22nd.
GMDANegative Net Change CALMNegative Net Change AAWWNegative Net Change
airlines consumer-staples medical
Company News for May 13, 2020
by Zacks Equity Research
Companies In The News Are: GMDA, NNVC, CHAP, YRCW
YRCWNegative Net Change NNVCNegative Net Change GMDANegative Net Change CHAPNegative Net Change
medical
New Strong Sell Stocks for March 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
HASPositive Net Change FLEXNegative Net Change LNDCNegative Net Change DKNegative Net Change GMDANegative Net Change
consumer-discretionary consumer-staples medical oil-energy semiconductor
Gamida Cell Enters Oversold Territory
by Zacks Equity Research
Gamida Cell has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
GMDANegative Net Change
medical
Gamida Cell Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Gamida Cell Ltd. (GMDA) has been struggling lately, but the selling pressure may be coming to an end soon.
GMDANegative Net Change
medical